Shadia I. Jalal

bahasa tutur atau tulis: Inggris

pendidikan: Universitas Yordania

pekerjaan: staf pengajar universitas, peneliti

laman resmi: medicine.iu.edu/faculty/5036/jalal-shadia

Seri

There is nothing here

Create a new serie

Karya

There is nothing here

Create a new work

Artikel 59

Date

Judul

Pengarang

2020-01-02

The Case for Maintenance Pemetrexed Plus Bevacizumab

Shadia I. Jalal
2020-04-17

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

Shadia I. Jalal
2020-07-22

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier cancer research network LUN 14-179

Greg A Durm, Shadia I. Jalal
2020-09-11

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

Martin H Voss, Shadia I. Jalal, Vicky Makker
2020-09-01

Tissue dynamics spectroscopic imaging: functional imaging of heterogeneous cancer tissue

Shadia I. Jalal
2020-09-28

Brief Report: Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

Shadia I. Jalal, Lecia V Sequist
2020-10-09

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?

Shadia I. Jalal
2019-07-01

Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors

Shadia I. Jalal
2019-04-01

Doppler fluctuation spectroscopy of intracellular dynamics in living tissue

Shadia I. Jalal, Michael O. Childress
2019-12-20

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

Shadia I. Jalal, Jan H M Schellens
2019-03-25

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

Hyun Cheol Chung, Charles S. Fuchs, Shadia I. Jalal, Yung-Jue Bang
2019-06-28

Acceptance and Commitment Therapy for Symptom Interference in Advanced Lung Cancer and Caregiver Distress: A Pilot Randomized Trial

Ekin Secinti, Victoria L. Champion, Catherine E. Mosher, Shadia I. Jalal, Shelley A. Johns
2019-04-16

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

Tanya Siddiqi, Shadia I. Jalal
2018-01-20

Coping Skills Practice and Symptom Change: A Secondary Analysis of a Pilot Telephone Symptom Management Intervention for Lung Cancer Patients and their Family Caregivers.

Victoria L. Champion, Catherine E. Mosher, Shadia I. Jalal, DuyKhanh P. Ceppa, Kenneth A. Kesler, Thomas J. Birdas, Joseph G. Winger
2018-03-15

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

Toshihiko Doi, Charles S. Fuchs, Shadia I. Jalal, Yung-Jue Bang, Atsushi Ohtsu
2018-08-20

24-Month Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab As First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

Leena Gandhi, Vassiliki Papadimitrakopoulou, Shadia I. Jalal, Lecia V Sequist
2018-08-23

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

Peter Tsai, Pratha Budhani, Arthur Liu, Shadia I. Jalal, Courtney Lynch, Trevor McKee, Mark Zaidi, Bradly Wouters, Cristin Print, Francis W Hunter
2018-02

Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers

Victoria L. Champion, Catherine E. Mosher, Shadia I. Jalal, Shelley A. Johns
2018-09-17

Social correlates of mental health in gastrointestinal cancer patients and their family caregivers: Exploring the role of loneliness

Ekin Secinti, Shelley A. Johns, Catherine E. Mosher, Shadia I. Jalal
2018-06-08

Outcomes of a novel intrathoracic esophagogastric anastomotic technique

Shadia I. Jalal, Karen M. Rieger, DuyKhanh P. Ceppa, Kenneth A. Kesler, Thomas J. Birdas
2018-08-01

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma

Shadia I. Jalal
2018-08-06

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study

Karen Kelly, Pilar Garrido, Mariano Provencio, Shadia I. Jalal
2018-12-17

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H

Shadia I. Jalal, Lecia V Sequist
2017-02-04

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

Shadia I. Jalal, Mrinal Gounder
2017-12-01

Blood-based tumor biomarkers in lung cancer for detection and treatment

Tony Mok, Shadia I. Jalal
2017-11-08

Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma.

Toshihiko Doi, Shadia I. Jalal
2017-01-05

Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device.

Norman D Brault, Onur Gur, Shadia I. Jalal
2017-12-03

Spontaneous Pneumothoraces and Hemothoraces in Sarcomas.

Shadia I. Jalal
2017-06-12

Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE).

Gregory K Lo, Shadia I. Jalal
2017-12-01

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer

Shadia I. Jalal
2016-04

DNA repair targeted therapy: The past or future of cancer treatment?

Catherine R. Sears, Shadia I. Jalal
2016-10-10

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

Leena Gandhi, Vassiliki Papadimitrakopoulou, Shadia I. Jalal, Lecia V Sequist, Hossein Borghaei, Corey J Langer

Human - wd:Q91794500

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut